Zepbound

Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
CNBC
Tue, 02/25/25 - 11:14 am
Eli Lilly
Zepbound
weight loss
LillyDirect
Wegovy and Ozempic stars dim amid overuse concerns
Axios
Tue, 02/11/25 - 11:17 am
Wegovy
Ozempic
Zepbound
Mounjaro
Novo Nordisk
Eli Lilly
GLP-1 agonists
obesity
patients
physicians
side effects
Ozempic-Like Drugs May Hold Risks For Surgical Patients, Officials Say
Forbes
Fri, 01/31/25 - 10:59 am
surgery
GLP-1 agonists
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Zepbound
Mounjaro
New Zepbound TV Commercial Inspires ‘Change’
Xtalks
Wed, 01/29/25 - 07:25 pm
Eli Lilly
Zepbound
DTC advertising
television ads
Large study of Novo, Lilly weight loss drugs shows decrease in risk of Alzheimer's
Fierce Pharma
Tue, 01/21/25 - 07:13 pm
Novo Nordisk
Eli Lilly
GLP-1 agonists
Wegovy
Ozempic
Zepbound
Mounjaro
Alzheimer's disease
arthritis
Novo Nordisk touts 'superior' weight loss results in study of high-dose Wegovy
Fierce Pharma
Fri, 01/17/25 - 11:34 am
Novo Nordisk
obesity
semaglutide
Wegovy
Eli Lilly
Zepbound
clinical trials
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, Health Department agency says
CNBC
Wed, 01/8/25 - 11:07 pm
Eli Lilly
Zepbound
Medicare
sleep apnea
Use of diabetes and anti-obesity drugs surges nationwide
Axios
Fri, 01/3/25 - 10:07 am
obesity
diabetes
Eli Lilly
Novo Nordisk
Ozempic
Wegovy
Mounjaro
Zepbound
GLP-1 agonist
Lilly’s Obesity Drug Zepbound To Be Key 2025 Health Cost Driver
Forbes
Wed, 01/1/25 - 10:49 pm
Eli Lilly
Zepbound
insurance
Zepbound, Mounjaro shortages are resolved, FDA confirms
BioPharma Dive
Thu, 12/19/24 - 09:36 pm
FDA
Eli Lilly
Zepbound
Mounjaro
drug shortages
Eli Lilly is going to test Zepbound as a treatment for addiction
Quartz
Wed, 12/11/24 - 10:44 pm
Eli Lilly
David Ricks
Zepbound
addiction
alcohol-use disorder
Lilly to offer single-dose vials of weight-loss drug on telehealth platform Ro
Yahoo Finance
Wed, 12/11/24 - 11:01 am
Eli Lilly
Ro
telehealth
Zepbound
Lilly’s Zepbound beats Novo’s Wegovy in high-stakes obesity drug trial
BioPharma Dive
Wed, 12/4/24 - 11:02 am
Eli Lilly
Zepbound
Novo Nordisk
Wegovy
clinical trials
weight loss
obesity
Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
Pharma Live
Tue, 12/3/24 - 11:36 am
Novo Nordisk
India
Wegovy
Eli Lilly
Zepbound
Why Amgen's Weight Loss Result Is a Win for Eli Lilly
Motley Fool
Wed, 11/27/24 - 11:30 am
Amgen
MariTide
Eli Lilly
Zepbound
Biden proposes Medicare and Medicaid cover weight loss drugs
Axios
Tue, 11/26/24 - 09:51 am
Joe Biden
Medicare
Medicaid
obesity
Novo Nordisk
Eli Lilly
Zepbound
Wegovy
Ozempic
Survey Finds Most GLP-1 Users Discontinue Drug Before Reaching Goal Weight
Xtalks
Fri, 11/15/24 - 11:27 am
Omada Health
GLP-1 agonists
obesity
weight loss
Novo Nordisk
Eli Lilly
Ozempic
Zepbound
Mounjaro
Wegovy
Eli Lilly’s weight-loss drug helps nearly 99% of patients remain diabetes-free
Pharma Live
Thu, 11/14/24 - 11:21 am
Eli Lilly
weight loss
tirzepatide
Mounjaro
Zepbound
diabetes
States slow to cover GLP-1s for weight loss
Axios
Wed, 11/6/24 - 11:37 am
Medicaid
GLP-1 agonists
Novo Nordisk
Eli Lilly
Wegovy
Zepbound
Lilly shares fall as obesity drug sales miss forecasts
BioPharma Dive
Wed, 10/30/24 - 11:52 am
Eli Lilly
earnings
obesity
Zepbound
Mounjaro

Pages